Title: Genetic Factors Associated with Patient-specific Warfarin Dose in Ethnic Indonesians

1. I found it interesting that the clinical factors alone only accounted for 7.6% of the variability in dosing and were not significant but this moved to 27.5% with the addition of the genetic tests (p<0.05). Might be interesting to discuss this in the discussion (from Table 5). Also most prior studies have found that the combination of factors here account for 40% of the variability perhaps the authors could comment on that as well.